Latest news

This recognition is awarded to companies that ensure the highest quality and efficiency criteria

We are thrilled to announce that Mats Sundgren, PhD, MSc, a distinguished expert in Health Data Strategy, has joined IOMED as a Scientific Advisor.

Thanks to our advanced platform for health data activation, we’ve revolutionized clinical research.

IOMED was part of the Innovation Day organized by Health Living Lab Son Espases

IOMED will participate as sponsor in the European OHDSI Symposium, an event where results and ideas on OMOP-CDM use, tool development and future research are shared.

As a sponsor of the event, IOMED will present a speech on how artificial intelligence serves as a key data activator. EHDS represents a crucial initiative to build a data-driven healthcare ecosystem

IOMED’s CEO, Rohit Mistry, will talk about unlocking the value of Real-World Data, and how Artificial Intelligence improves clinical research, enabling the acceleration of patient recruitment processes and the reduction of research timelines at Global Clinical Trials Connect, which will take place on May 28 and 29 at the Hilton London Kensington (United Kingdom).

The recent edition of the Health Revolution Congress witnessed a remarkable display of synergy and innovation as Google Cloud and IOMED joined forces to explore the transformative power of healthcare data. The collaborative session, held amidst eager anticipation, proved to be a highlight of the event.

We take a further step in our commitment to medicine with the aim of creating a community around the potential of technology to improve research.

Google Cloud & IOMED will conduct two tracks within the framework of the Health Revolution Congress, featuring the participation of sector experts. The sessions will showcase success cases in Health and Technology, emphasizing the power of data as a catalyst for change in the healthcare ecosystem.

The Health Revolution Congress stands as the largest European Summit in Digital Health, where startups and global stakeholders convene in Barcelona on May 16th.

IOMED will be part of a round table at the Health Revolution Congress, the largest European summit on Digital Health.

IOMED, a leader in healthcare data activation, has announced the appointment of Rohit Mistry as its new Chief Executive Officer (CEO).

IOMED will participate as a sponsor at the 14th Annual Outsourcing in Clinical Trials Europe 2024 (OCTEU), event where pharmaceutical and biotechnological leaders can find solutions to current challenges, taking place on May 7th and 8th in Barcelona.

Today, the European Parliament has taken a monumental step towards a stronger European Health Union with the adoption of the European Health Data Space (EHDS).

The journey has been developed around three round tables: how will be the hospital of the future, clinical studies in the framework of a European proposal and the secondary use of data for research and artificial intelligence.

4YFN celebrates its tenth edition this year and one of the novelties is the incorporation of a new pavilion dedicated to the health sector.

Artificial Intelligence enables the acceleration of patient recruitment processes and the reduction of research timelines.

This distinguished label is bestowed upon companies showcasing an outstanding level of innovation in their initiatives, as acknowledged by the European Commission.

The CB Insights Digital Health 50 of 2023 honorees were selected from a pool of more than 10,000 companies

The Artificial Intelligence company IOMED has launched several training sessions in healthcare centres such as the Hospital Universitario Fundación Alcorcón (Madrid) and the Hospital de Sant Pau (Barcelona).

IOMED's co-founder and CTO Gabriel Maeztu gave an engaging workshop at PyDay BCN held at the University of Barcelona on 11 November.

In just six years, IOMED has become a leading company in Artificial Intelligence in healthcare, with a nationwide presence and ongoing expansion into European countries.

Philips Ventures -the venture capital group of health technology leader Philips- and XTX Ventures -the venture capital arm of leading algorithmic trading company XTX Markets-, led the latest funding round of IOMED. Fondo Bolsa Social and Redseed also participated in the round, as well as IOMED’s existing investors Adara Ventures and EASO Ventures.

The tech team has collaborated with the research group at HITZ to create an annotated corpus of medical sections.

Artificial intelligence will allow the Clinic to analyze millions of clinical data in one-tenth of the time it takes for manual processes.

IOMED's technology significantly reduces the time required for obtaining clinical research data.

The Cantabrian Health Service (SCS) will be the first in Spain to fully embrace artificial intelligence (AI), developed by IOMED Medical Solutions, to structure electronic health records (EHR) across its entire healthcare system.